Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.8720
+0.0021 (0.24%)
At close: Jun 6, 2025, 4:00 PM
0.8890
+0.0170 (1.95%)
After-hours: Jun 6, 2025, 7:42 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Dysregulated Transcription Therapeutics
6.29M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
6.29M